CHEK2 c. 1100delC may not contribute to genetic background of hereditary breast cancer from Shanghai of China

Chinese Journal of Medical Genetics

Volumn 23, Issue 4, 2006, Pages 443-445

  Song, Chuan Gui ^a,b   Hu, Zhen ^a   Yuan, Wen Too ^c   Di, Gen Hong ^a   Shen, Zhen Zhou ^a   Huang, Wei ^c   Shao, Zhi Ming ^a  

^a FUDAN UNIVERSITY   (China)

^b FUJIAN MEDICAL UNIVERSITY   (China)

^c CHINESE NATIONAL HUMAN GENOME CENTER AT SHANGHAI   (China)

Author keywords

BRCA1 gene; BRCA2 gene; Breast cancer; CHEK2 gene; Genetic susceptibility

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; CHECKPOINT KINASE 2;

ARTICLE; BREAST CANCER; CHINA; CONTROLLED STUDY; DNA SEQUENCE; EXON; FAMILIAL CANCER; FAMILY HISTORY; FRAMESHIFT MUTATION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; HUMAN; POLYMERASE CHAIN REACTION; PREVALENCE;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; CHINA; DNA MUTATIONAL ANALYSIS; FEMALE; FRAMESHIFT MUTATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; MUTATION, MISSENSE; PROTEIN-SERINE-THREONINE KINASES; SEQUENCE DELETION; YOUNG ADULT;

EID: 33747682139     PISSN: 10039406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Bartek J, Falck J, Lukas J. CHK2 kinase: a busy messenger. Nat Rev Mol Cell Biol, 2001, 2:877-886.
2. Wu X, Webster SR, Chen J. Characterization of tumor-associated Chk2 mutations. J Biol Chem, 2001, 276:2971-2974.
3. Meijers-Heijboer H, van den Ouweland A, Hijn J, et al. Low-penetrance susceptibility to breast cancer due to CHK2 * 1100delC in non-carriers of BRCA1 or BRCA2 mutations. Nat Genet, 2002, 31:55-59.
4. Vahteristo P, Bartkova J, Eerola H, et al. A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. Am J Hum-Genet, 2002, 71:432-438.
5. Hu Z, Wu J, Liu CH, et al. The analysis of BRCA1 mutations in eastern Chinese patients with early onset breast cancer and affected relatives. Hum Mutat, 2003, 22:104.
6. Song CG, Hu Z, Yuan WT, et al. BRCA1 and BRCA2 gene mutations of familial breast cancer from Shanghai in China. Chin J Med Genet, 2006, 23:27-31.
7. Sodha N, Houlston RS, Williams R, et al. A robust method for detecting CHK2/RAD53 mutations in genomic DNA. Hum Mutat, 2002, 19:173-177.
8. Anglian Breast Cancer Study Group. Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Br J Cancer, 2000, 83:1301-1308.
9. Lee JS, Collins M, Brown AL, et al. hCds1-mediated phoephorylation of BRCA1 regulates the DNA damage response. Nature, 2000, 404:201-204.
10. Offit K, Pierce H, Kirchhoff T, et al. Frequency of CHEK2 * 1100delC in New York breast cancer cases and controls. BMC Med Genet, 2003, 4:1.
11. Osorio A, Rodriguez-Lopez R, Diez O, et al. The breast cancer low-penetrance allele 1 100delC in the CHEK2 gene is not present in Spanish familial breast cancer population. Int J Cancer, 2004, 108:54-56.
12. Dufault MR, Bete B, Wappenschmidt B, et al. Limited relevance of the CHEK2 gene in hereditary breast cancer. Int J Cancer, 2004, 110:320-325.